Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
delayed orgasm.
Popular Articles

Martinez: Fixing Long-Term Care, Starting With The Census
U.S. Senator Mel Martinez (R-FL) introduced an effort aimed at updating the U.S. Census" current function questions to better improve our nation"s long-term care services and support systems. By replacing a small portion of the survey with standardized function questions used by medical providers, the Disability Data Modernization Act will provide more accurately collected data used for planning the future health care needs of elderly and disabled Americans.
generic viagra
Pfizer Introduces New Treatment And Support Plan For Patients With Overactive Bladder
Pfizer Inc announced today that Toviaz™ (fesoterodine fumarate) extended release tablets and the YourWay™ plan (http://www.ToviazYourWay.com), a comprehensive, customizable support plan for overactive bladder patients, are available in the United States. Toviaz is a once-daily prescription treatment for patients with symptoms of overactive bladder, which include frequent and sudden urges to urinate and wetting accidents. Toviaz works by helping to calm the bladder muscle that causes frequent, sudden urges to urinate.
News of the day
NYT Examines Effects Of Illegal Abortion On Maternal Mortality In Tanzania
The New York Times on Tuesday examined how botched abortion procedures contribute to maternal mortality in Tanzania, in the second of a three-part series on pregnancy- and childbirth-related deaths in the country. The Times reports that the lack of abortion rights in Tanzania -- where the procedure is illegal except in cases where the woman"s life or health is at risk -- has prompted pregnant women and girls to seek the procedure from people who have not been trained to perform such procedures. In some cases, these untrained providers give the pregnant women herbs before performing abortions by punching the pregnant women"s stomachs or inserting objects into the vagina and uterus. Local hospitals in Tanzania often have to correct mistakes made by the untrained abortion providers. For example, during the month of January, 17 of the 31 minor surgical procedures performed at one Tanzanian hospital were to correct the results of "incomplete abortions."Africa has the world"s highest maternal mortality rate -- at least 100 times that of developed countries -- making pregnancy and childbirth among the most serious health dangers that African women face, according to the Times. Abortion accounts for a significant portion of those deaths. Tanzania has a maternal mortality rate of 950 deaths for every 100,000 births, a figure that is "neither the best nor the worst in Africa," the Times reports.Because most abortions in Tanzania are performed illegally, there are no reliable abortion figures for the country. However, the World Health Organization estimates that Eastern Africa, where Tanzania is located, has the world"s second-highest rate of unsafe abortions. Abortion rates typically decrease with increased contraceptive use, the Times reports. Only about one-quarter of Tanzanians use contraception in part because of misinformation that girls receive about the safety of condoms and hormonal contraceptives. By comparison, Kenya and South Africa both have higher contraception use and lower maternal mortality. However, in countries such as Sierra Leone and Nigeria, where abortion is not available on request, contraception use is lower than in Tanzania, and maternal mortality is much higher (Grady, New York Times, 6/2).
Medical Devices

New York Times Examines Debate Surrounding Use Of Experimental Treatments In Terminally Ill Patients

Some patient advocates are lobbying to legalize "compassionate use" of experimental drugs for people with terminal illnesses who have exhausted other treatments, prompting a debate about how and when to provide such patients with treatments that could prolong their lives, the New York Times reports. Most insurers do not cover unproven treatments, and physicians have concerns that using experimental treatment could give patients false hope and cause unnecessary pain. Drugmakers are concerned that if there are unfavorable outcomes from providing patients with an unproven treatment, it could hurt the drug"s chances of receiving FDA approval. At the same time, FDA does not want to grant drugs and their makers the opportunity to skip clinical trials. Currently, patients must individually apply to receive treatments through compassionate use (Harmon, New York Times, 5/17). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009